MDxHealth (MDXH) EBT Growth (1y) (2022 - 2026)
MDxHealth (MDXH) EBT Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn | 12.58% |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn | 64.58% |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn | 15.14% |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn | 56.92% |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn | -6.81% |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn | -27.03% |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn | -15.03% |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn | 16.39% |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn | 7.29% |
| 10 | MDxHealth | 21.37 Mn | -21.78 Mn | 16.61 Mn | 2.26% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.26% |
| Dec 31, 2025 | -54.57% |
| Sep 30, 2025 | -129.17% |
| Jun 30, 2025 | 99.28% |
| Mar 31, 2025 | -6.59% |
| Dec 31, 2024 | 36.63% |
| Sep 30, 2024 | -8.06% |
| Jun 30, 2024 | -8.49% |
| Mar 31, 2024 | 27.31% |
| Dec 31, 2023 | 12.92% |
| Sep 30, 2023 | 26.31% |
| Jun 30, 2023 | 99.94% |
| Mar 31, 2023 | -41.58% |
| Dec 31, 2022 | -52.31% |
| Sep 30, 2022 | -78.86% |